Copyright Reports & Markets. All rights reserved.

Global Cyanocobalamin API Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Cyanocobalamin API Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Cyanocobalamin API by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Cyanocobalamin API by Country/Region, 2017, 2022 & 2028
  • 2.2 Cyanocobalamin API Segment by Type
    • 2.2.1 Crystal
    • 2.2.2 Powder
  • 2.3 Cyanocobalamin API Sales by Type
    • 2.3.1 Global Cyanocobalamin API Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Cyanocobalamin API Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Cyanocobalamin API Sale Price by Type (2017-2022)
  • 2.4 Cyanocobalamin API Segment by Application
    • 2.4.1 Contract Manufacturing Organizations
    • 2.4.2 Pharmaceutical Companies
    • 2.4.3 Others
  • 2.5 Cyanocobalamin API Sales by Application
    • 2.5.1 Global Cyanocobalamin API Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Cyanocobalamin API Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Cyanocobalamin API Sale Price by Application (2017-2022)

3 Global Cyanocobalamin API by Company

  • 3.1 Global Cyanocobalamin API Breakdown Data by Company
    • 3.1.1 Global Cyanocobalamin API Annual Sales by Company (2020-2022)
    • 3.1.2 Global Cyanocobalamin API Sales Market Share by Company (2020-2022)
  • 3.2 Global Cyanocobalamin API Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Cyanocobalamin API Revenue by Company (2020-2022)
    • 3.2.2 Global Cyanocobalamin API Revenue Market Share by Company (2020-2022)
  • 3.3 Global Cyanocobalamin API Sale Price by Company
  • 3.4 Key Manufacturers Cyanocobalamin API Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Cyanocobalamin API Product Location Distribution
    • 3.4.2 Players Cyanocobalamin API Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cyanocobalamin API by Geographic Region

  • 4.1 World Historic Cyanocobalamin API Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Cyanocobalamin API Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Cyanocobalamin API Annual Revenue by Geographic Region
  • 4.2 World Historic Cyanocobalamin API Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Cyanocobalamin API Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Cyanocobalamin API Annual Revenue by Country/Region
  • 4.3 Americas Cyanocobalamin API Sales Growth
  • 4.4 APAC Cyanocobalamin API Sales Growth
  • 4.5 Europe Cyanocobalamin API Sales Growth
  • 4.6 Middle East & Africa Cyanocobalamin API Sales Growth

5 Americas

  • 5.1 Americas Cyanocobalamin API Sales by Country
    • 5.1.1 Americas Cyanocobalamin API Sales by Country (2017-2022)
    • 5.1.2 Americas Cyanocobalamin API Revenue by Country (2017-2022)
  • 5.2 Americas Cyanocobalamin API Sales by Type
  • 5.3 Americas Cyanocobalamin API Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Cyanocobalamin API Sales by Region
    • 6.1.1 APAC Cyanocobalamin API Sales by Region (2017-2022)
    • 6.1.2 APAC Cyanocobalamin API Revenue by Region (2017-2022)
  • 6.2 APAC Cyanocobalamin API Sales by Type
  • 6.3 APAC Cyanocobalamin API Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Cyanocobalamin API by Country
    • 7.1.1 Europe Cyanocobalamin API Sales by Country (2017-2022)
    • 7.1.2 Europe Cyanocobalamin API Revenue by Country (2017-2022)
  • 7.2 Europe Cyanocobalamin API Sales by Type
  • 7.3 Europe Cyanocobalamin API Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Cyanocobalamin API by Country
    • 8.1.1 Middle East & Africa Cyanocobalamin API Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Cyanocobalamin API Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Cyanocobalamin API Sales by Type
  • 8.3 Middle East & Africa Cyanocobalamin API Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Cyanocobalamin API
  • 10.3 Manufacturing Process Analysis of Cyanocobalamin API
  • 10.4 Industry Chain Structure of Cyanocobalamin API

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Cyanocobalamin API Distributors
  • 11.3 Cyanocobalamin API Customer

12 World Forecast Review for Cyanocobalamin API by Geographic Region

  • 12.1 Global Cyanocobalamin API Market Size Forecast by Region
    • 12.1.1 Global Cyanocobalamin API Forecast by Region (2023-2028)
    • 12.1.2 Global Cyanocobalamin API Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Cyanocobalamin API Forecast by Type
  • 12.7 Global Cyanocobalamin API Forecast by Application

13 Key Players Analysis

  • 13.1 Sanofi
    • 13.1.1 Sanofi Company Information
    • 13.1.2 Sanofi Cyanocobalamin API Product Offered
    • 13.1.3 Sanofi Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Sanofi Main Business Overview
    • 13.1.5 Sanofi Latest Developments
  • 13.2 North China Pharmaceutical Group
    • 13.2.1 North China Pharmaceutical Group Company Information
    • 13.2.2 North China Pharmaceutical Group Cyanocobalamin API Product Offered
    • 13.2.3 North China Pharmaceutical Group Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 North China Pharmaceutical Group Main Business Overview
    • 13.2.5 North China Pharmaceutical Group Latest Developments
  • 13.3 Kingvit
    • 13.3.1 Kingvit Company Information
    • 13.3.2 Kingvit Cyanocobalamin API Product Offered
    • 13.3.3 Kingvit Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Kingvit Main Business Overview
    • 13.3.5 Kingvit Latest Developments
  • 13.4 Basic Nutrition
    • 13.4.1 Basic Nutrition Company Information
    • 13.4.2 Basic Nutrition Cyanocobalamin API Product Offered
    • 13.4.3 Basic Nutrition Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Basic Nutrition Main Business Overview
    • 13.4.5 Basic Nutrition Latest Developments
  • 13.5 EuroAPI
    • 13.5.1 EuroAPI Company Information
    • 13.5.2 EuroAPI Cyanocobalamin API Product Offered
    • 13.5.3 EuroAPI Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 EuroAPI Main Business Overview
    • 13.5.5 EuroAPI Latest Developments
  • 13.6 Rochem International
    • 13.6.1 Rochem International Company Information
    • 13.6.2 Rochem International Cyanocobalamin API Product Offered
    • 13.6.3 Rochem International Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Rochem International Main Business Overview
    • 13.6.5 Rochem International Latest Developments
  • 13.7 Hebei Yuxing Bio-Engineering
    • 13.7.1 Hebei Yuxing Bio-Engineering Company Information
    • 13.7.2 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Offered
    • 13.7.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Hebei Yuxing Bio-Engineering Main Business Overview
    • 13.7.5 Hebei Yuxing Bio-Engineering Latest Developments
  • 13.8 Wockhardt
    • 13.8.1 Wockhardt Company Information
    • 13.8.2 Wockhardt Cyanocobalamin API Product Offered
    • 13.8.3 Wockhardt Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Wockhardt Main Business Overview
    • 13.8.5 Wockhardt Latest Developments
  • 13.9 Bristol Myers Squibb
    • 13.9.1 Bristol Myers Squibb Company Information
    • 13.9.2 Bristol Myers Squibb Cyanocobalamin API Product Offered
    • 13.9.3 Bristol Myers Squibb Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Bristol Myers Squibb Main Business Overview
    • 13.9.5 Bristol Myers Squibb Latest Developments
  • 13.10 Hebei Huarong Pharmaceutical
    • 13.10.1 Hebei Huarong Pharmaceutical Company Information
    • 13.10.2 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Offered
    • 13.10.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Hebei Huarong Pharmaceutical Main Business Overview
    • 13.10.5 Hebei Huarong Pharmaceutical Latest Developments
  • 13.11 Antibiotice
    • 13.11.1 Antibiotice Company Information
    • 13.11.2 Antibiotice Cyanocobalamin API Product Offered
    • 13.11.3 Antibiotice Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Antibiotice Main Business Overview
    • 13.11.5 Antibiotice Latest Developments
  • 13.12 GlaxoSmithKline
    • 13.12.1 GlaxoSmithKline Company Information
    • 13.12.2 GlaxoSmithKline Cyanocobalamin API Product Offered
    • 13.12.3 GlaxoSmithKline Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 GlaxoSmithKline Main Business Overview
    • 13.12.5 GlaxoSmithKline Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Cyanocobalamin API will have significant change from previous year. According to our (LP Information) latest study, the global Cyanocobalamin API market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cyanocobalamin API market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cyanocobalamin API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cyanocobalamin API market, reaching US$ million by the year 2028. As for the Europe Cyanocobalamin API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Cyanocobalamin API players cover Sanofi, North China Pharmaceutical Group, Kingvit, and Basic Nutrition, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cyanocobalamin API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Crystal
Powder

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Contract Manufacturing Organizations
Pharmaceutical Companies
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
North China Pharmaceutical Group
Kingvit
Basic Nutrition
EuroAPI
Rochem International
Hebei Yuxing Bio-Engineering
Wockhardt
Bristol Myers Squibb
Hebei Huarong Pharmaceutical
Antibiotice
GlaxoSmithKline
Buy now